HCM
MD icon

Highbridge Capital Management’s Pediatrix Medical MD Stock Holding History

Highbridge Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,200
Closed -$311K – 1830
2017
Q3 		$311K Buy
+7,200
New +$342K ﹤0.01% 1180

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Highbridge Capital Management's MD Position: Q3 2018 in Review

Highbridge Capital Management sold out of Pediatrix Medical (MD) in Q3 2018, closing a stake of 124,386 shares — an estimated $5.38M sold.

Highbridge Capital Management first reported a position in MD in Q3 2014 and held it in 4 quarters. The position peaked at $7.16M in Q1 2018. 320 funds tracked by Wall St. Rank hold MD as of Q3 2018.

  • Highbridge Capital Management reported no remaining Pediatrix Medical position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 124,386 Pediatrix Medical shares in Q3 2018, an estimated $5.38M.
  • Highbridge Capital Management first reported a position in Pediatrix Medical in Q3 2014 and held it in 4 quarters.
  • Highbridge Capital Management's Pediatrix Medical position peaked at $7.16M in Q1 2018.
  • 320 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.